Induction of p53‐independent growth inhibition in lung carcinoma cell A549 by gypenosides

Publisher： John Wiley & Sons Inc

E-ISSN： 1582-4934|19|7|1697-1709

ISSN： 1582-1838

Source： Journal of Cellular and Molecular Medicine, Vol.19, Iss.7, 2015-07, pp. : 1697-1709

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Honokiol inhibits in vitro and in vivo growth of oral squamous cell carcinoma through induction of apoptosis, cell cycle arrest and autophagy

By  

Journal of Cellular and Molecular Medicine, Vol. 22, Iss. 3, 2018-03 ,pp. : 1894-1908

John Wiley & Sons Inc

Access to resources Recommend Favorite

Wild‐type p53 enhances endothelial barrier function by mediating RAC1 signalling and RhoA inhibition

By  

Journal of Cellular and Molecular Medicine, Vol. 22, Iss. 3, 2018-03 ,pp. : 1792-1804

John Wiley & Sons Inc

Access to resources Recommend Favorite

Dedifferentiation of patient‐derived glioblastoma multiforme cell lines results in a cancer stem cell‐like state with mitogen‐independent growth

By  

Journal of Cellular and Molecular Medicine, Vol. 19, Iss. 6, 2015-06 ,pp. : 1262-1272

John Wiley & Sons Inc

Access to resources Recommend Favorite

miR‐134 inhibits non‐small cell lung cancer growth by targeting the epidermal growth factor receptor

By  

Journal of Cellular and Molecular Medicine, Vol. 20, Iss. 10, 2016-10 ,pp. : 1974-1983

John Wiley & Sons Inc

Access to resources Recommend Favorite

Significance of tumour cell HLA‐G5/‐G6 isoform expression in discrimination for adenocarcinoma from squamous cell carcinoma in lung cancer patients

By  

Journal of Cellular and Molecular Medicine, Vol. 19, Iss. 4, 2015-04 ,pp. : 778-785

John Wiley & Sons Inc

Access to resources Recommend Favorite